Repaglinide

Repaglinide (Prandin®, NovoNorm®, GlucoNorm®), an oral insulin secretagogue, was the first meglitinide analogue to become available for use in patients with type 2 diabetes mellitus. The drug lowers postprandial glucose excursions by targeting early-phase insulin release, an effect thought to be important in reducing long-term cardiovascular complications… CONTINUE READING